Industry: Medical Devices & Consumables
Published Date: 2024-07-01
Pages: 119 Pages
Report ld: 3220329
Request Sample
Customized Report
Deep brain stimulation is an established technique for the treatment of movement disorders related to neurodegenerative diseases such as Parkinson's disease (PD) and essential tremor (ET). Its application seems also feasible for the treatment of neuropsychiatric disorders such as treatment resistant depression (TRD) and Tourette's syndrome (TS). In a typical deep brain stimulation system, the amount of current delivered to the patients is constant and regulated by the physician. Conversely, an adaptive deep brain stimulation system (aDBS) is a closed loop system that adjusts the stimulation parameters according to biomarkers which reflect the patient's clinical state.
The global Adaptive Neuromodulation Therapy Devices market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
The US & Canada market for Adaptive Neuromodulation Therapy Devices is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The China market for Adaptive Neuromodulation Therapy Devices is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The Europe market for Adaptive Neuromodulation Therapy Devices is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key manufacturers of Adaptive Neuromodulation Therapy Devices include Medtronic plc, Amber Therapeutics, Newronika SPA, Genlight, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for Adaptive Neuromodulation Therapy Devices, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Adaptive Neuromodulation Therapy Devices, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Adaptive Neuromodulation Therapy Devices, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Adaptive Neuromodulation Therapy Devices sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Adaptive Neuromodulation Therapy Devices market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Adaptive Neuromodulation Therapy Devices sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Medtronic plc, Amber Therapeutics, Newronika SPA, Genlight, etc.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Adaptive Neuromodulation Therapy Devices in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Adaptive Neuromodulation Therapy Devices manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Adaptive Neuromodulation Therapy Devices sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Adaptive Neuromodulation Therapy Devices Product Introduction
1.2 Market by Type
1.2.1 Global Adaptive Neuromodulation Therapy Devices Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Single-channel
1.2.3 Dual Channels
1.3 Market by Application
1.3.1 Global Adaptive Neuromodulation Therapy Devices Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Epilepsy
1.3.3 Parkinson's Disease (PD)
1.3.4 Mixed urinary incontinence (MUI)
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Adaptive Neuromodulation Therapy Devices Revenue Estimates and Forecasts 2019-2030
2.2 Global Adaptive Neuromodulation Therapy Devices Revenue by Region
2.2.1 Global Adaptive Neuromodulation Therapy Devices Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Adaptive Neuromodulation Therapy Devices Revenue by Region (2019-2024)
2.2.3 Global Adaptive Neuromodulation Therapy Devices Revenue by Region (2025-2030)
2.2.4 Global Adaptive Neuromodulation Therapy Devices Revenue Market Share by Region (2019-2030)
2.3 Global Adaptive Neuromodulation Therapy Devices Sales Estimates and Forecasts 2019-2030
2.4 Global Adaptive Neuromodulation Therapy Devices Sales by Region
2.4.1 Global Adaptive Neuromodulation Therapy Devices Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Adaptive Neuromodulation Therapy Devices Sales by Region (2019-2024)
2.4.3 Global Adaptive Neuromodulation Therapy Devices Sales by Region (2025-2030)
2.4.4 Global Adaptive Neuromodulation Therapy Devices Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Adaptive Neuromodulation Therapy Devices Sales by Manufacturers
3.1.1 Global Adaptive Neuromodulation Therapy Devices Sales by Manufacturers (2019-2024)
3.1.2 Global Adaptive Neuromodulation Therapy Devices Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Adaptive Neuromodulation Therapy Devices in 2023
3.2 Global Adaptive Neuromodulation Therapy Devices Revenue by Manufacturers
3.2.1 Global Adaptive Neuromodulation Therapy Devices Revenue by Manufacturers (2019-2024)
3.2.2 Global Adaptive Neuromodulation Therapy Devices Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Adaptive Neuromodulation Therapy Devices Revenue in 2023
3.3 Global Key Players of Adaptive Neuromodulation Therapy Devices, Industry Ranking, 2021 VS 2022
3.4 Global Adaptive Neuromodulation Therapy Devices Sales Price by Manufacturers (2019-2024)
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Adaptive Neuromodulation Therapy Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Adaptive Neuromodulation Therapy Devices, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Adaptive Neuromodulation Therapy Devices, Product Offered and Application
3.8 Global Key Manufacturers of Adaptive Neuromodulation Therapy Devices, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Adaptive Neuromodulation Therapy Devices Sales by Type
4.1.1 Global Adaptive Neuromodulation Therapy Devices Historical Sales by Type (2019-2024)
4.1.2 Global Adaptive Neuromodulation Therapy Devices Forecasted Sales by Type (2025-2030)
4.1.3 Global Adaptive Neuromodulation Therapy Devices Sales Market Share by Type (2019-2030)
4.2 Global Adaptive Neuromodulation Therapy Devices Revenue by Type
4.2.1 Global Adaptive Neuromodulation Therapy Devices Historical Revenue by Type (2019-2024)
4.2.2 Global Adaptive Neuromodulation Therapy Devices Forecasted Revenue by Type (2025-2030)
4.2.3 Global Adaptive Neuromodulation Therapy Devices Revenue Market Share by Type (2019-2030)
4.3 Global Adaptive Neuromodulation Therapy Devices Price by Type
4.3.1 Global Adaptive Neuromodulation Therapy Devices Price by Type (2019-2024)
4.3.2 Global Adaptive Neuromodulation Therapy Devices Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Adaptive Neuromodulation Therapy Devices Sales by Application
5.1.1 Global Adaptive Neuromodulation Therapy Devices Historical Sales by Application (2019-2024)
5.1.2 Global Adaptive Neuromodulation Therapy Devices Forecasted Sales by Application (2025-2030)
5.1.3 Global Adaptive Neuromodulation Therapy Devices Sales Market Share by Application (2019-2030)
5.2 Global Adaptive Neuromodulation Therapy Devices Revenue by Application
5.2.1 Global Adaptive Neuromodulation Therapy Devices Historical Revenue by Application (2019-2024)
5.2.2 Global Adaptive Neuromodulation Therapy Devices Forecasted Revenue by Application (2025-2030)
5.2.3 Global Adaptive Neuromodulation Therapy Devices Revenue Market Share by Application (2019-2030)
5.3 Global Adaptive Neuromodulation Therapy Devices Price by Application
5.3.1 Global Adaptive Neuromodulation Therapy Devices Price by Application (2019-2024)
5.3.2 Global Adaptive Neuromodulation Therapy Devices Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Adaptive Neuromodulation Therapy Devices Market Size by Type
6.1.1 US & Canada Adaptive Neuromodulation Therapy Devices Sales by Type (2019-2030)
6.1.2 US & Canada Adaptive Neuromodulation Therapy Devices Revenue by Type (2019-2030)
6.2 US & Canada Adaptive Neuromodulation Therapy Devices Market Size by Application
6.2.1 US & Canada Adaptive Neuromodulation Therapy Devices Sales by Application (2019-2030)
6.2.2 US & Canada Adaptive Neuromodulation Therapy Devices Revenue by Application (2019-2030)
6.3 US & Canada Adaptive Neuromodulation Therapy Devices Market Size by Country
6.3.1 US & Canada Adaptive Neuromodulation Therapy Devices Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Adaptive Neuromodulation Therapy Devices Revenue by Country (2019-2030)
6.3.3 US & Canada Adaptive Neuromodulation Therapy Devices Sales by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Adaptive Neuromodulation Therapy Devices Market Size by Type
7.1.1 Europe Adaptive Neuromodulation Therapy Devices Sales by Type (2019-2030)
7.1.2 Europe Adaptive Neuromodulation Therapy Devices Revenue by Type (2019-2030)
7.2 Europe Adaptive Neuromodulation Therapy Devices Market Size by Application
7.2.1 Europe Adaptive Neuromodulation Therapy Devices Sales by Application (2019-2030)
7.2.2 Europe Adaptive Neuromodulation Therapy Devices Revenue by Application (2019-2030)
7.3 Europe Adaptive Neuromodulation Therapy Devices Market Size by Country
7.3.1 Europe Adaptive Neuromodulation Therapy Devices Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Adaptive Neuromodulation Therapy Devices Revenue by Country (2019-2030)
7.3.3 Europe Adaptive Neuromodulation Therapy Devices Sales by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Adaptive Neuromodulation Therapy Devices Market Size by Type
8.1.1 China Adaptive Neuromodulation Therapy Devices Sales by Type (2019-2030)
8.1.2 China Adaptive Neuromodulation Therapy Devices Revenue by Type (2019-2030)
8.2 China Adaptive Neuromodulation Therapy Devices Market Size by Application
8.2.1 China Adaptive Neuromodulation Therapy Devices Sales by Application (2019-2030)
8.2.2 China Adaptive Neuromodulation Therapy Devices Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Adaptive Neuromodulation Therapy Devices Market Size by Type
9.1.1 Asia Adaptive Neuromodulation Therapy Devices Sales by Type (2019-2030)
9.1.2 Asia Adaptive Neuromodulation Therapy Devices Revenue by Type (2019-2030)
9.2 Asia Adaptive Neuromodulation Therapy Devices Market Size by Application
9.2.1 Asia Adaptive Neuromodulation Therapy Devices Sales by Application (2019-2030)
9.2.2 Asia Adaptive Neuromodulation Therapy Devices Revenue by Application (2019-2030)
9.3 Asia Adaptive Neuromodulation Therapy Devices Market Size by Region
9.3.1 Asia Adaptive Neuromodulation Therapy Devices Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Adaptive Neuromodulation Therapy Devices Revenue by Region (2019-2030)
9.3.3 Asia Adaptive Neuromodulation Therapy Devices Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
9.3.9 Australia
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Adaptive Neuromodulation Therapy Devices Market Size by Type
10.1.1 Middle East, Africa and Latin America Adaptive Neuromodulation Therapy Devices Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Adaptive Neuromodulation Therapy Devices Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Adaptive Neuromodulation Therapy Devices Market Size by Application
10.2.1 Middle East, Africa and Latin America Adaptive Neuromodulation Therapy Devices Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Adaptive Neuromodulation Therapy Devices Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Adaptive Neuromodulation Therapy Devices Market Size by Country
10.3.1 Middle East, Africa and Latin America Adaptive Neuromodulation Therapy Devices Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Adaptive Neuromodulation Therapy Devices Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Adaptive Neuromodulation Therapy Devices Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Corporate Profile
11.1 Medtronic plc
11.1.1 Medtronic plc Company Information
11.1.2 Medtronic plc Overview
11.1.3 Medtronic plc Adaptive Neuromodulation Therapy Devices Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Medtronic plc Adaptive Neuromodulation Therapy Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Medtronic plc Recent Developments
11.2 Amber Therapeutics
11.2.1 Amber Therapeutics Company Information
11.2.2 Amber Therapeutics Overview
11.2.3 Amber Therapeutics Adaptive Neuromodulation Therapy Devices Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Amber Therapeutics Adaptive Neuromodulation Therapy Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Amber Therapeutics Recent Developments
11.3 Newronika SPA
11.3.1 Newronika SPA Company Information
11.3.2 Newronika SPA Overview
11.3.3 Newronika SPA Adaptive Neuromodulation Therapy Devices Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Newronika SPA Adaptive Neuromodulation Therapy Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Newronika SPA Recent Developments
11.4 Genlight
11.4.1 Genlight Company Information
11.4.2 Genlight Overview
11.4.3 Genlight Adaptive Neuromodulation Therapy Devices Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Genlight Adaptive Neuromodulation Therapy Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Genlight Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Adaptive Neuromodulation Therapy Devices Industry Chain Analysis
12.2 Adaptive Neuromodulation Therapy Devices Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Adaptive Neuromodulation Therapy Devices Production Mode & Process
12.4 Adaptive Neuromodulation Therapy Devices Sales and Marketing
12.4.1 Adaptive Neuromodulation Therapy Devices Sales Channels
12.4.2 Adaptive Neuromodulation Therapy Devices Distributors
12.5 Adaptive Neuromodulation Therapy Devices Customers
13 Adaptive Neuromodulation Therapy Devices Market Dynamics
13.1 Adaptive Neuromodulation Therapy Devices Industry Trends
13.2 Adaptive Neuromodulation Therapy Devices Market Drivers
13.3 Adaptive Neuromodulation Therapy Devices Market Challenges
13.4 Adaptive Neuromodulation Therapy Devices Market Restraints
14 Key Findings in the Global Adaptive Neuromodulation Therapy Devices Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Adaptive Neuromodulation Therapy Devices market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 74
USD 4250.00
(Single User License)
The global Adaptive Neuromodulation Therapy Devices market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 122
USD 4900.00
(Single User License)
The global market for Adaptive Neuromodulation Therapy Devices was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-19
Pages: 87
USD 3950.00
(Single User License)
The global Adaptive Neuromodulation Therapy Devices market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-15
Pages: 90
USD 2900.00
(Single User License)
The global Adaptive Neuromodulation Therapy Devices market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 117
USD 4900.00
(Single User License)
The global Adaptive Neuromodulation Therapy Devices market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 71
USD 4250.00
(Single User License)
The global market for Adaptive Neuromodulation Therapy Devices was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 80
USD 3950.00
(Single User License)
The global market for Adaptive Neuromodulation Therapy Devices was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-10
Pages: 77
USD 2900.00
(Single User License)
Deep brain stimulation is an established technique for the treatment of movement disorders related to neurodegenerative diseases such as Parkinson's disease (PD) and essential tremor (ET). Its application seems also feasible for the treatment of neuropsychiatric disorders such as treatment resistant depression (TRD) and Tourette's syndrome (TS). In a typical deep brain stimulation system, the amount of current delivered to the patients is constant and regulated by the physician. Conversely, an adaptive deep brain stimulation system (aDBS) is a closed loop system that adjusts the stimulation parameters according to biomarkers which reflect the patient's clinical state.
Published Date: 2024-07-01
Pages: 88
USD 4350.00
(Single User License)
Deep brain stimulation is an established technique for the treatment of movement disorders related to neurodegenerative diseases such as Parkinson's disease (PD) and essential tremor (ET). Its application seems also feasible for the treatment of neuropsychiatric disorders such as treatment resistant depression (TRD) and Tourette's syndrome (TS). In a typical deep brain stimulation system, the amount of current delivered to the patients is constant and regulated by the physician. Conversely, an adaptive deep brain stimulation system (aDBS) is a closed loop system that adjusts the stimulation parameters according to biomarkers which reflect the patient's clinical state.
Published Date: 2024-07-01
Pages: 74
USD 2900.00
(Single User License)
The global Adaptive Neuromodulation Therapy Devices market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 74
The global Adaptive Neuromodulation Therapy Devices market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 122
The global market for Adaptive Neuromodulation Therapy Devices was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-19
Pages: 87
The global Adaptive Neuromodulation Therapy Devices market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-15
Pages: 90
The global Adaptive Neuromodulation Therapy Devices market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 117
The global Adaptive Neuromodulation Therapy Devices market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 71
The global market for Adaptive Neuromodulation Therapy Devices was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 80
The global market for Adaptive Neuromodulation Therapy Devices was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 77
Deep brain stimulation is an established technique for the treatment of movement disorders related to neurodegenerative diseases such as Parkinson's disease (PD) and essential tremor (ET). Its application seems also feasible for the treatment of neuropsychiatric disorders such as treatment resistant depression (TRD) and Tourette's syndrome (TS). In a typical deep brain stimulation system, the amount of current delivered to the patients is constant and regulated by the physician. Conversely, an adaptive deep brain stimulation system (aDBS) is a closed loop system that adjusts the stimulation parameters according to biomarkers which reflect the patient's clinical state.
Published: 2024-07-01
Pages: 88
Deep brain stimulation is an established technique for the treatment of movement disorders related to neurodegenerative diseases such as Parkinson's disease (PD) and essential tremor (ET). Its application seems also feasible for the treatment of neuropsychiatric disorders such as treatment resistant depression (TRD) and Tourette's syndrome (TS). In a typical deep brain stimulation system, the amount of current delivered to the patients is constant and regulated by the physician. Conversely, an adaptive deep brain stimulation system (aDBS) is a closed loop system that adjusts the stimulation parameters according to biomarkers which reflect the patient's clinical state.
Published: 2024-07-01
Pages: 74
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now